2024 International Congress » Parkinson's Disease: Non-Motor Symptoms

A Network Analysis shows How Impulsive-Compulsive Behaviors correlates with Levodopa-Induced Dyskinesia

B. Veiga, C. Silva, S. Silva, R. Saba, H. Ferraz, V. Borges (São Paulo, Brazil)

A Nomogram Model for Predicting Malnutrition among Patients with Parkinson’s Disease

Q. Huang, X. Zou (Chengdu, China)

Aberrant connectivity in Resting-State Brain Networks Underlying Neuropsychiatric Symptoms in Prodromal Lewy Body Dementia.

L. Wright, P. Donaghy, D. Burn, J-P. Taylor, J. O'Brien, A. Yarnall, F. Matthews, M. Firbank, H. Sigurdsson, J. Schumacher, A. Thomas, R. Lawson (Newcastle upon Tyne, United Kingdom)

Age of Onset and Non-Motor Symptoms in Early Parkinson’s Disease: A Data-Analysis Study Based on the Fox Insight Cohort

A. Oliveira Franco, D. Teixeira-Dos-Santos, A. Noyce, S. Bandres-Ciga, A. Schumacher Schuh (Porto Alegre, Brazil)

Assessment of pain in people with Parkinson’s disease: an exploratory survey of international nursing experiences

C. Tedesco, M. Petralito, R. Caruso, G. Pucciarelli (Rome, Italy)

Association Between Hypertension Timing and Clinical Variables in Parkinson’s Disease: A Retrospective Analysis

WF. Moguel Cardín, AL. Guerra Anzaldo, GA. Espinosa Cruz, A. Adam Castro, A. Dominguez García, A. Cervantes Arriaga, M. Rodríguez Violante, AJ. Hernández Medrano, G. Rivera Monroy, K. Velázquez Román, RJ. Baños Betancourt, CF. álvarez Hernández, DP. Romero Terán, JC. Delgado Uriarte, NP. Moreno Aldama, MC. Unda Mcfarlane, A. Uribe León (Ciudad de Mexico, Mexico)

Association Between Motor Symptoms and Autonomic Dysfunction in De Novo Parkinson’s Disease: Insights into the Role of the Gut-Brain Axis

KY. Kwon, JE. Park (Seoul, Republic of Korea)

Association of Autonomic Symptoms with Motor Features of Parkinson’s Disease in the Nigeria Parkinson’s Disease Research Network Registry

E. Nwazor, O. Ojo, O. Agabi, N. Okubadejo, NPD. Research Network (Port Harcourt, Nigeria)

Association of insomnia with levodopa-related parameters in Parkinson’s disease

L. Atabekyan, N. Nadryan, E. Balian, H. Karkourian, H. Hovakimyan, Z. Tavadyan, S. Khachatryan (Yerevan, Armenia)

Autonomic dysfunction and its impact on quality of life in Mexican people living with PD

MF. Medina Pérez, D. Lopez Galindo, AJ. Hernandez Medrano, DP. Romero Terán, SF. Arechavala Lopez, G. Rivera Monroy, KI. Sanchez Ramirez, A. Abundes Corona, A. Cervantes Arriaga, M. Rodríguez Violante (Mexico, Mexico)

Autonomic Dysfunction in Parkinson’s Disease Link with disease severity and other non-motor signs

A. Mousli, R. Zouari, A. Rachdi, F. Nabli, D. Ben Mohamed, Z. Saeid, S. Ben Sassi (Ariana, Tunisia)

Behavior medicine perspectives in pre-DBS patients with ET and PD

D. Kim, S. O'Neill, S. Murthy, A. Waters, C. Palmese (Bronx, USA)

Behavioral health characteristics of pre-surgical Focused Ultrasound and Deep Brain Stimulation candidates

D. Kim, S. O'Neill, S. Murthy, A. Waters, C. Palmese (Bronx, USA)

Beyond constipation: gastrointestinal phenomena in Parkinson’s disease

MA. Silveira, H. Dourado, G. Procópio, M. Sampaio, IJ. Oliveira, L. Almeida, G. Valença (Salvador, Brazil)

Brainstem Monoaminergic Degeneration, Cognition, and Autonomic Symptom Progression in Early Parkinson’s Disease

KA. Woo, SY. Kim, HY. Choi, JH. Shin, HJ. Kim (Seoul, Republic of Korea)

Changes in slow-wave sleep characteristics in Parkinson’s disease patients with depression

C. Mao, J. Hu, Y. Wang, X. Cheng, J. Liu, F. Wang, C. Liu (Suzhou, China)

Characteristics of vegetative disorders in Parkinson’s disease patients with Covid-19

O. Naimov, R. Matmurodov, B. Muminov (Tashkent, Uzbekistan)

Clinical and Neuroimaging Biomarker Predictors of Autonomic Dysfunction in Parkinson’s Disease: A Study Using PPMI Data

A. Oliveira Franco, M. Machado Schlindwein, J. Rossi Catao, D. Teixeira-Dos-Santos, A. Bieger, T. Hugentobler Schlickmann, L. Angi Souza, C. Mattjie, F. Suzuki, G. Magalhães Pereira, L. Silveira Kupssinskü, L. Vinícius Moura, R. Ravazio, S. Duarte Pinto, M. de Bastiani, R. Barros, E. Zimmer, A. Schumacher Schuh (Porto Alegre, Brazil)

Clinical correlates of apathy in Parkinson´s disease

J. Arena, L. Fiorentini, C. Obarrio, M. Merello (Buenos Aires, Argentina)

Clinical Predictors of Impulse Control Disorders in Parkinson’s Disease

T. Breddy, P. Macdonald, K. van Hedger, H. Ganjavi (London, Canada)

Comparasion of Motor, Non-motor, Social Aspects between Women with Parkinson’s Disease with and Without Sexual Dysfunction

K. Nobrega, B. Alexandre, M. Braga, A. Helene, A. Roque, I. Nascimento, M. Piemonte (Sao Paulo, Brazil)

Comparative Effectiveness of Behavioral or Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease

C. Vaughan, J. Morley, J. Lehosit, G. Mcgwin, L. Muirhead, A. Khakharia, T. Johnson Ii, M. Evatt, T. Sergent, K. Burgio, A. Markland (Atlanta, USA)

Comparison of Age, Cognitive, Autonomic, and Motor Testing between Serotonergic vs Idiopathic REM-Sleep Behavior Disorder

M. Berns, N. Reddy, H. Olson, R. Berns, M. Howell (Minneapolis, USA)

Comparison of Gastrointestinal Dysfunction in Early-onset and Late-onset Parkinson’s Disease

C. Arora, N. Kamble, V. Holla, R. Mahale, R. Yadav, P. Pal (BENGALURU, India)

Comparison of Motor, Non-motor, Social Aspects between Men with Parkinson’s Disease with and without Erectile Dysfunction

K. Nobrega, B. Souza, B. Alexandre, M. Silva, A. Frazao, A. Roque, I. Nascimento, ME. Piemonte (Sao Paulo, Brazil)

Constipation in Early-Onset Parkinson’s Disease: frequency, time of onset and association with mortality

C. Piat, A. Mullan, K. Ghoniem, P. Turcano, J. Bower, E. Benarroch, R. Savica (Rochester, USA)

Contrasting Olfactory Perception in Parkinson’s Disease: Impact of GBA1 Gene Mutations

Y. Schechter, M. Dominko, M. Cohen, G. Yahalom, A. Zimran, S. Revel-Vilk, E. Shulman, T. Dinur, M. Becker Cohen (jerusalem, Israel)

Criteria Defining Chronic Pain Associated with Parkinson Disease

S. Perez-Lloret, J. Hunger, J. Bally, G. Kägi, J. Möller, N. Hollenstein, R. Gonzenbach, F. Brugger, D. Ciampi-de-Andrade, V. Mylius (Buenos Aires, Argentina)

Decoding Fatigue in Parkinson’s Disease: Exploring Multifactorial Associations

F. Sarmento, G. Lamp, V. Srikar Lavu, A. S. Madamangalam, J. K. Wong (Gainesville, USA)

Deep learning-based Prediction of Visual Dysfunction in Parkinson’s Disease from 31 Brain Regions of Interest using Quantitative Diffusion MRI

C. Raimondo, L. Singanamala, M. Alizadeh (Philadelphia, USA)

Designing a Device for Real-time Monitoring and Digital Integration of Non-motor Symptoms

C. Gundler, A. Wiederhold, F. ückert (Hamburg, Germany)

Detecting impulsivity through speech in patients with Parkinson’s Disease: A principle proof study

T. Thies, E. Mallick, S. Jost, J. Tröger, M. Barbe (Cologne, Germany)

Determinants of nocturnal arterial hypertension in Parkinson’s disease patients in Cameroon

D. Gams Massi, J. Ndjock, A. Magnerou, Y. Mapoure Njankouo (Douala, Cameroon)

Dissecting Neural Circuits Regulating Sleep State Transitions in a Mouse Model of Parkinson’s Disease

P. Marcott, A. Nelson (San Francisco, USA)

Dual Frequency Stimulation of the Subthalamic Nucleus Improves Emotional State in Parkinson’s Disease

E. Pegolo, F. Cucinotta, I. Hossain, B. Ishihara, M. Hart, E. Pereira, F. Morgante, A. Fasano, L. Ricciardi (Padova, Italy)

Dysphagia is Frequent in early Parkinson´s Disease. Results from a 5-year Follow-up Study.

D. Santos, T. de Deus, C. Cores, C. íñiguez, L. Samaniego, J. Paz González, S. Jesús, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, Z. Mendoza, I. Pareés, P. Sánchez Alonso, G. Alonso Losada, M. Morales, I. Gastón, J. Kulisevsky, M. Seijo, C. Valero, R. Alonso Redondo, M. Buongiorno, C. Ordás, P. Martínez Martín, P. Mir, C. Coppadis (A Coruña, Spain)

Effect of Orthostatic Hypotension Medications on Orthostatic Ratio: A Systemic Review and Meta-Analysis

V. Pham, M. Rashid, B. Kung, S. Hossain (Toledo, USA)

Effect on Cognition and Affect in Patients with Deep Brain Stimulation for Parkinson’s Disease from Low Socioeconomic Status

D. Nguyen, R. Parihar, J. Shen, N. Baxi (Bronx, USA)

Effects on Speech After the Use of Swallow Against Resistance Exercise Device in Parkinson’s Disease Patients

R. Lee, H. Hassan, E. Jackowiak, R. Brennan, M. Kern, R. Shaker (Milwaukee, USA)

Episodes of Hypoglycemia in Patients with Parkinson’s Disease – Results of Two-Week Continuous Glucose Monitoring

T. Chmiela, A. Gorzkowska (Katowice, Poland)

Evaluating the Impact of the Pain Self-Management Program in PD

A. Zawar (Lynnwood, USA)

Examining the Effects of Deep Brain Stimulation on Speech in Parkinson’s Disease

H. Kabakoff, A. Mogilner, M. Pourfar, A. Flinker (Brooklyn, USA)

Exploring Supervised and Real-World Mobility in People with Parkinson’s Disease with and without Nocturnal Hypokinesia

E. Bianchini, D. Rinaldi, S. Galli, M. Alborghetti, L. de Carolis, P. Petit, P. Pacilio, T. Milane, C. Hansen, FE. Pontieri, N. Vuillerme (Rome, Italy)

Exploring the Influence of Gastrointestinal Symptoms on Non-Motor Fluctuations in Parkinson’s Disease: Insights from the ReMePark-2, a Mexican Cohort

A. Cervantes-Arriaga, AJ. Hernández Medrano, AL. Guerra-Anzaldo, A. Domínguez-García, DP. Romero-Terán, G. Rivera-Monroy, KI. Sánchez-Ramírez, MF. Medina-Pérez, M. Rodríguez-Violante, R. Baños-Betancourt, A. Abundes-Corona, SF. Arechavala Lopez, WF. Moguel-Cardín ()

Exploring the Influence of Sleep Disorders on Speech Intensity in Individual’s with Parkinson’s Disease

A. Senthinathan, K. Bean (Buffalo, USA)

Fatigue in Parkinson’s Disease: Prevalence and Risk Factors

C. Falup-Pecurariu, I. Murasan, D. Rusu, B. Opritoiu, L. Ungureanu, L. Irincu, I. Despa, S. Diaconu (Brasov, Romania)

Feasibility of a Web Application to Enable Social Interaction in the PREDICT-PD Cohort

L. Smith, X. Li, A. Gill, P. Panzarasa, J. Bestwick, A. Schrag, A. Noyce, A. de Simoni (London, United Kingdom)

Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO), A Novel Retinal Mitochondrial Biomarker For Parkinson’s Disease

K. Shivok, E. Affel, M. Alizadeh, T-W. Liang, D. Kremens, R. Sergott (Philadelphia, USA)

Gastrointestinal Dysbiosis and Clinical Outcomes in Parkinson’s Disease

K. Julio, A. Vakhtin, H. Lin, A. Birg, N. Hoffman, S. Nitschke, N. Shaff, E. Erhardt, A. Mayer, D. Sugar, G. Suarez Cedeno, A. Deligtisch, S. Pirio Richardson, S. Ryman (Albuquerque, USA)

Gender Disparities in Daytime Sleepiness Among Hispanic Individuals with Parkinson’s Disease: A Cross-Sectional Study

C. Rodriguez-Alarcon, D. Piana-Castillo, G. Faggioni-Sanchez, D. Bustamante-Mieles, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)

Gender-Based Differences in Sleep Quality Among Hispanic Parkinson’s Disease Patients

D. Piana-Castillo, C. Rodriguez-Alarcon, G. Faggioni-Sanchez, D. Bustamante-Mieles, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)

Impairment of REM Sleep Architecture: A Potential Biomarker for Parkinson’s Progression

A. Mirzazadeh, R. Levy, H. Rahul, R. Dorsey, A. Videnovic, D. Katabi (Cambridge, USA)

Influence of Fatigue in Parkinson’s Disease on Variability of Gait Measures

I. Sierra, S. Perfetto, A. Potvin-Desrochers, C. Mvomo, J. Bedime, H. Lajeunesse, F. Parent-L'Ecuye, C. Paquette (Montreal, Canada)

Integrating Non-Motor Symptoms and Gender Variability in Machine Learning for Early Parkinson’s Disease Detection

MZA. Ali, PSD. Dholaniya (Hyderabad, India)

Interim Report of Quality of Life Outcomes After Deep Brain Stimulation for Parkinson’s Disease from a Large Global Real-World Study

A. Gharabaghi, L. Lopez, A. Schnitzler, S. Chen, L. Himes, M. Frassica, D. Nanduri, S. Groppa (Tuebingen, Germany)

Investigating an Emerging Anxiety-like Phenotype in a Novel Bilateral Rodent Model of Parkinsonian Alpha-Synuclein Pathology

N. Lipari, I. Sandoval, F. Manfredsson, C. Bishop (Binghamton, USA)

Longitudinal patterns of Anxiety and Depression in patients with Parkinson’s Disease

O. Lawal, M. Morales, S. Shakya, J. Savitt, S. Reich, A. Gruber-Baldini, L. Shulman, R. von Coelln (Baltimore, USA)

Looking Away: Anxiety Interferes with the Ability of Freezers to Attend to Visual Cues

P. Norouzian, A. Zafar, S. Lewis, K. Ehgoetz Martens (Waterloo, Canada)

Mechanical and thermal thresholds in the MPTP macaque model of Parkinson’s disease

A. Sadoun, Q. Li, E. Pioli, T. Dhellemmes, M. Landry, E. Bezard (Floirac, France)

Misinterpretation of Hypnagogic/hypnopompic Experiences as Hallucinations in Parkinson’s Disease

D. Urso, V. Gnoni, A. Giugno, M. Caccamo, A. Nanni, G. Logroscino, G. Foffani (Tricase, Italy)

Molecular Landscape of Gastrointestinal Dysfunctions in Parkinson’s Disease

M. Lai, S. Kulkarni, B. Benitez (Boston, USA)

Mood and Apathy Outcomes after STN or GPi DBS for Parkinson’s Disease: An Interim Report from the ADROIT NAPA Sub-study

S. Groppa, M. Figee, I. Muro Garcia, A. Schnitzler, S. Chen, L. Himes, M. Frassica, D. Nanduri, A. Gharabaghi (Mainz, Germany)

Nocturnal Bradykinesia is better detected using wearable sensors in Parkinson’s disease compared to clinical outcome

I. Murasan, M. Qamar, K. Poplawska-Domaszewicz, D. Trivedi, K R. Chaudhuri, C. Falup-Pecurariu (Brasov, Romania)

Non-motor Symptoms and Quality-of-life of People with Parkinson’s disease

K. Prakash, X. Xiao, EC. Lim (Singapore, Singapore)

Nutritional Status Implication at 6 Months in Parkinson’s Disease: Follow-Up Results

N. Ayo Mentxakatorre, B. Tijero, T. Fernandez-Valle, A. Ortiz-de-Echevarria, M. Acera Gil, I. Chavarri Rubio, C. Juanes Moreno, M. Ruiz-Lopez, JC. Gomez-Esteban, R. Del Pino (Barakaldo, Spain)

Odor-specific symptoms in Parkinson’s disease – UPSIT odor identification status versus clinical severity.

YG. Guo, SC. Chiu (Taichung, Taiwan)

Orthostatic Hypotension：a Clinical Marker for the Body-First Subtype of Patients with Parkinson’s Disease

S. Mei, X. Wang, C. Han, P. Chan (Beijing, China)

Parkinson’s disease biomarkers in human olfactory cleft mucus

J. Morley, N. Cohen, S. Koganti, S. Wood, H. Wang (Philadelphia, USA)

Patients with Parkinson’s disease have frequently pincer nail deformity

M. Sakamoto, H. Nagayama, K. Kimura (Tokyo, Japan)

Personality of Parkinson’s disease patients may influence the development and evolution of non-motor fluctuations

M. Boussac, F. Faggianelli, E. Harroch, A. Eusebio, M. Fabbri, F. Ory-Magne, E. Descamps, O. Rascol, C. Laurencin, AR. Marques, M. Anheim, B. Giordana, L. Hopes, C. Moreau, AS. Rolland, D. Devos, D. Maltete, S. Ansquer, E. Hainque, S. Drapier, JP. Brandel, T. Rouaud, D. Guehl, B. Jarraya, M. Tir, T. Witjas, JP. Azulay, C. Brefel-Courbon (Toulouse, France)

Perspective of people living with early Parkinson’s Disease: most common, burdensome, and worrisome symptoms

S. Messner, T. Carmody, R. Park, B. Jones, A. Hursey, E. Lucassen (Basel, Switzerland)

Plasma NFL predicting fatigue conversion in early Parkinson’s disease

NN. Che (Chengdu, China)

Postural Stability Relates to Autonomic Dysfunction in Parkinson’s Disease

A. Homagain, K. Ehgoetz Martens (Waterloo, Canada)

Predicting prodromal Parkinson’s disease with a deep learning algorithm using medical and prescription data

WW. Lee, Y. Koo, M. Kim (Seoul, Republic of Korea)

Prevalence and characteristics of anxiety in Parkinson’s disease

I. Murasan, S. Diaconu, L. Ungureanu, I. Despa, A. Zarnoveanu, B. Opritoiu, C. Falup-Pecurariu (Brasov, Romania)

Prevalence of Autonomic Symptoms in Mexican Population with Parkinson’s Disease

A. Domínguez-García, A. Cervantes-Arriaga, M. Rodríguez-Violante, AJ. Hernández-Medrano, G. Rivera-Monroy, K. Velázquez-Román, AL. Guerra-Anzaldo, DP. Romero-Terán, WF. Moguel-Cardín, RJ. Baños-Betancourt, CF. álvarez-Hernández, D. Rebolledo-García (CDMX, Mexico)

Prevalence of Helicobacter Pylori Infection Among Nepalese Parkinson’s Disease Patients and their Clinical Manifestations

R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari, R. Hamal, A. Jha, R. Pathak (Kathmandu, Nepal)

Prevalence of Non-Motor Symptoms in Patients with Parkinson Disease in a Tertiary Hospital in Santiago, Chile.

M. Sánchez, V. Rosado, C. Montalva, P. Salles, J. Fuentes, P. Chaná (Santiago, Chile)

Prodromal Parkinson’s disease in the general population

G. de Klerk, T. van Laar, S. Meles (Groningen, Netherlands)

Prodromal RBD and the risk of cognitive impairment in Parkinson’s disease.

A. Martinez-Nunez, H. Hutchinson, V. Lavu, Q. Yuan, J. Dwarampudi, J. Wong (Gainesvile, USA)

Prospective and Controlled Glucocerebrosidase-related Parkinson’s Disease Evaluation of Non-Motor Symptoms (PROGENS-PD)

I. Muro, L. López-Manzanares, P. Lorenzo, E. Casas, B. González, J. Masabanda, A. Arroyo, A. Hurtado, JP. Romero (Madrid, Spain)

RBD Unmasked: LRRK2 and the Prodromal Path to Parkinson’s Disease

M. Acharya, S. Datta, N. Ghosh, B. Chakraborty (Kharagpur, India)

SCN9A Gene Variant in a PD Case with Refractory Dysesthesias

J. Park, B. Barton (Chicago, USA)

Shifting Tides of Caffeine: Evaluating Consumption Patterns In Parkinson’s disease Progression

S. Bouhadoun, S. Zolfaghari, A. Delva, T. Kouchache, A. Pelletier, R. Postuma (Montréal, Canada)

Speech features in Korean Parkinson’s disease patients: A prospective cohort study

D. Yoo, S. Cho, J. Kim, J. Bang (Seoul, Republic of Korea)

Subjective Sleep Quality and Pathological Sleepiness in Veterans with Parkinson’s Disease

A. Sarwar (PEARLAND, USA)

The assessment of anxiety and depression comorbidities and the DRN electrophysiology in a primate model of Parkinson’s Disease

A. Sadoun, M. Deffains, Q. Li, E. Bezard, F. Georges, E. Pioli (Floirac, France)

The Association between Non-Motor Symptom Burden and Quality of Life in the Nigeria Parkinson Disease Research Network Registry

O. Odeniyi, O. Ojo, O. Agabi, N. Okubadejo, NPD. Research Network (Lagos, Nigeria)

The Association of Pain with motor symptom severity in Parkinson’s Disease: A secondary data analysis

N. Pacheco-Barrios, V. Gagliardi, R. Grudtner, I. Njokanma, K. Acurio, J. Rolston, B. Illigens, F. Fregni, K. Pacheco-Barrios (Boston, USA)

The Contribution of Cognitive and Affective Factors to Balance Control in People with Parkinson’s Disease Attending an Outpatient Clinic

E. Spasova, C. O'Keeffe, A. Blanco-Campal, J. Inocentes, C. Fearon, R. Reilly (Dublin, Ireland)

The Effect of an Exogenous Ketone Supplement on Gut Microbiota in Parkinson’s disease, a Pilot Study

V. Vedam-Mai, M. Beke, V. Mai, P. Mackie, E. Klann, A. Gurrala, S. Chua, E. Ince, L. Almeida, A. Ramirez-Zamora (Gainesville, USA)

The effect of comorbid chronic post-traumatic stress disorder in dream enactment behavior among veterans with Parkinson’s disease and REM sleep behavior disorder

E. Sandoval, C. Josephs, T. Lin (Tucson, USA)

The effect of Diabetes Mellitus and Cardiovascular disease on Parkinson’s disease

T. Abali, SN. Kibrit, Z. özdamar, İ. Köker, AV. Karacan, MK. Yekedüz, R. Yilmaz, FT. Eminoglu, MC. Akbostancı (Ankara, Turkey)

Transcranial Magnetic Stimulation of Median Prefrontal Cortex Improves Orthostatic Hypotension in Parkinson’s Disease

S. Antipenko, A. Frohlich, M. Sklerov (Chapel Hill, USA)

Transcutaneous tibial nerve stimulation for overactive bladder symptoms in Parkinson’s disease: results from a phase II randomised control trial (STRIPE)

M. Smith, A. Cullen, G. Portlock, M. Drake, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

TRPV1: A Potential Therapeutic Target for Inflammation and Pain in Parkinson’s Disease

SJ. Song, YE. Kim (Anyang, Republic of Korea)

Two parallel nigrostriatal subcircuits mediate the arousal effect of dopaminergic neurons in substantia nigra pars compacta

HS. Liu, JW. Li, ZA. Hu, RC. Ren, XN. Xiong (Wuhan, China)

Uncovering Non-Motor Subtypes in Parkinson’s Disease through Machine Learning

G. Pinilla-Monsalve, Y. Song, A. Young, A. Hanganu, O. Monchi (Montreal, Canada)

Untangling Bidirectional Influences of Somatic and Internalizing Symptoms among People with Parkinson’s Disease: A Retrospective Cohort Study

E. Demarco, D. Subramaniam, J. Scherrer, G. Grossberg, L. Hinyard (St. Louis, USA)

Unveiling Parkinson’s Disease Risk Factors in the European Population-Based HeBA Cohort

A. Garrido, C. Horlings, K. Rege, S. Schade, S. Ghosh, P. Mahlknecht, R. Rawal, T. Marques, D. Pilco, C. Gomes, C. Pauly, F. Farfan, D. Mcintyre, K. Seppi, MJ. Marti, C. Trenkwalder, W. Poewe, E. Tolosa, V. Satagopam, R. Krüger, B. Mollenhauer (Barcelona, Spain)

Unwinding Anxiety: Feasibility and Effectiveness of App-Based Mindfulness Training for People with Anxiety and Parkinson’s Disease: A Pilot Study

E. Weisbach, A. Demarco, J. Molino, A. Seritan, P. Prakash (Providence, USA)

Validation of the International Parkinson and Movement Disorder Society – Non-Motor Symptoms – Questionnaire (MDS-NMS-Q)

D. Weintraub, KR. Chaudhuri, A. Schrag, P. Martinez-Martin, A. Rizos, E. Mamikonyan, J. Gallagher, J. Staunton, M. Pereira Fernandes, C. Rodriguez Blazquez (Philadelphia, USA)

When Off Can Cost Life: Myocardial Infarction Due to Spontaneous Coronary Dissection as a Catastrophic Manifestation in Advanced Parkinson’s Disease.

S. Poveda, T. Lopez, B. Pascual Sedano, A. Campolongo (Bogotá, Colombia)